sham oxygen (room air)

DRUG4 trials

Sponsors

University of Zurich

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Interstitial Lung DiseasePrecapillary Pulmonary Hypertension

Phase 4

Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise Performance

CompletedNCT02143609

University of ZurichChronic Obstructive Pulmonary Disease (COPD)

Start: 2014-05-31End: 2014-10-31Updated: 2019-05-14

Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance

CompletedNCT02143687

University of ZurichInterstitial Lung Disease, Precapillary Pulmonary Hypertension

Start: 2014-05-31End: 2021-10-31Updated: 2021-10-07

Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and Sleep

CompletedNCT02150590

University of ZurichChronic Obstructive Pulmonary Disease (COPD)

Start: 2014-06-01End: 2014-10-31Updated: 2019-01-29

Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep

University of ZurichInterstitial Lung Disease, Precapillary Pulmonary Hypertension

Start: 2014-05-31End: 2020-12-31Target: 50Updated: 2020-02-06

Related Papers

Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trial.

2021-10-136 citations

Effect of Nocturnal Oxygen Therapy on Daytime Pulmonary Hemodynamics in Patients With Chronic Obstructive Pulmonary Disease Traveling to Altitude: A Randomized Controlled Trial

Frontiers in Physiology2021-07-075 citations

Effect of nocturnal oxygen therapy on next-day exercise performance of COPD patients at 2048m. Data from a RCT

2020-09-07

Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters

JAMA Network Open2020-06-2228 citations